These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2336814)

  • 21. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J
    Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D; Eriksson JW; Boman K; Svensson MK
    Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Dunstan DW; Mori TA; Puddey IB; Beilin LJ; Burke V; Morton AR; Stanton KG
    Thromb Haemost; 1999 Mar; 81(3):367-72. PubMed ID: 10102462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in the determinants of fibrinolytic activity.
    MacCallum PK; Cooper JA; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 1998 Mar; 79(3):587-90. PubMed ID: 9531046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coagulative and fibrinolytic blood activity in diabetic angiopathy (author's transl)].
    Kaniak J; Kurzawska M; Kotschy M; Paczyńska D; Moszczynska D; Prastowski W; Kozlowska B; Czarnacki M
    Przegl Lek; 1977; 34(6):527-33. PubMed ID: 905590
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
    Weinrauch LA; Gleason RE; Keough J; D'Elia JA
    Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide.
    Ceriello A; Quatraro A; Marchi E; Barbanti M; Giugliano D
    Diabete Metab; 1993; 19(2):225-9. PubMed ID: 8339853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinolytic activity in Nigerian diabetics with renal insufficiency.
    Unuigbe EI; Famodu AA; Umunna CE
    Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood fibrinolysis and ischemic disease of the myocardium in diabetes mellitus].
    Barbui T; Di Luzio V; Gambari PF; Previato G; Castellani A
    Cuore Circ; 1969 Apr; 53(2):49-62. PubMed ID: 5403949
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic activity, autonomic neuropathy, and circulation in diabetes mellitus.
    Almér LO; Sundkvist G; Lilja B
    Diabetes; 1983 May; 32 Suppl 2():4-7. PubMed ID: 6600036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvascular disease and limited joint mobility in diabetes. A comparison of fibrinolysis and prostacyclin in diabetes and systemic sclerosis.
    Larkin JG; Belch JJ; Flanigan P; Forbes CD; Frier BM
    Diabet Med; 1988 Jan; 5(1):53-6. PubMed ID: 2964329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.